Author: Digirad

COVID-19 Resources for Nuclear Cardiologists & Radiologists

Nuclear Medicine departments and providers are being impacted by the COVID-19 crisis in unprecedented ways. We’re closely monitoring the latest developments, and in this post we take a look at four areas that are impacting nuclear cardiology. COVID-19 Best Practices & Preparedness for Nuclear Cardiologists ANSC held an informative webcast

Read More »

Real Ways That Artificial Intelligence Will Change Cardiology

Artificial intelligence is developing rapidly in medicine, including in the field of cardiology. If you’ve been to conferences in the last couple of years, you’ve probably seen presentations on some aspect of artificial intelligence. Quite simply, AI involves computer systems performing tasks that usually require human intelligence. They do this

Read More »

The SNMMI Value Initiative: What You Need to Know

Have you heard of the SNMMI Value Initiative? Founded by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Value Initiative includes an industry alliance, of which Digirad is a member, providing a forum for the industry to work in partnership. We are excited by the strategic vision for

Read More »

What Is the Difference Between SPECT and PET Imaging for Cardiology?

Cardiac imaging is a critical technology, particularly as cardiovascular disease is the leading cause of mortality for most developed nations. While SPECT remains the leading modality for cardiac imaging, PET has continued to see growing interest. Naturally, patients and physicians want to know if one is better than the other

Read More »

Technetium-99m Availability: Production and Industry Update

Overall this year, there has been some unsteadiness in the supply chain for Moly-99 (Mo-99), which in turn affects the supply of technetium-99m (Tc-99m). For operators of gamma cameras, availability of the radiopharmaceutical gives cause for concern. David Pellicciarini, Vice President, Pharmacy Safety, Practice & Technical Operations for Cardinal Health,

Read More »

Mobile Imaging for Y90 Studies

If you diagnose or treat patients with liver cancer, then you’re probably familiar with the procedure for Yttrium-90 (Y90) studies. In short, the patient must go through a mapping process to ensure that the medical team gets the best possible information from which to treat them. This involves examining the

Read More »
Making Healthcare Convenient. As Needed. When Needed. Where Needed.

Sign Up!

Subscribe to the Digirad Newsletter for the latest updates.

©2020 Digirad Corporation. All rights reserved.